Clinical TrialID 7239
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
NCT00213278
Glioma
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7239
- Evidence Id
- 7239
- Core Evidence Id
- 7239
- Source Clinical Trial Id
- 7229
- Herb2 Clinical Trial Id
- HBCT007229
- Nct Id
- NCT00213278
- Title
- Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Glioma
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: vinblastine sulphate injection
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 50
- Outcome Measure
- To determine the response rate to Vinblastine in recurrent low grade glioma of childhood, 52 weeks
- Sponsor Collaborator
- The Hospital for Sick Children|Ontario Cancer Research Network
- Funded By
- OTHER
- Location
- The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada
- Other Id
- 20010429
- Start Date
- 2002-01
- Primary Completion Date
- 2011-09
- Completion Date
- 2012-09
- First Posted
- 2005-09-21
- Results First Posted
- Last Update Posted
- 2014-11-20
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00213278
- Title Cn
- Title En
- Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
- Bilingual Status
- semi_complete